The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge (2024)
Attributed to:
Further development of infectious bronchitis virus vaccines adapted for production in cell culture
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0297516
Publication URI: http://dx.doi.org/10.1371/journal.pone.0297516
Type: Journal Article/Review
Parent Publication: PLOS ONE
Issue: 1